Business Models for eHealth - Final Report

Business Models for eHealth - Final Report
This report presents the analysis of a study funded by the ICT for Health Unit to explore business models for the implementation of value-creating and sustainable eHealth systems in Europe. It also introduces a set of policy recommendations for the European Commission and other stakeholders, with the ultimate objectives being: a) the improvement of the overall quality and efficiency of provision of health services in general via eHealth services, taking into consideration the present and future socio-economic and financial challenges faced by national healthcare authorities in Europe; b) the consolidation of eHealth services as a mature market where European industry can play a leading role via the provision of innovative technological and organisational solutions.

The first objective refers to the use of eHealth services and solutions to improve overall healthcare delivery. As argued in the opening stages of the report, these information technology (IT)-enhanced healthcare services can support healthcare delivery organisations and health authorities to provide responses to factors such as Europe's ageing population, the growing prominence of chronic diseases and financial challenges in controlling overall healthcare spending. The second objective refers to the fact that eHealth services and solutions can provide the appropriate responses previously indicated if industry delivers the appropriate technological solutions. Actually, as argued in the report, eHealth represents a substantial market where European industrial players can have a pivotal role.

Download Business Models for eHealth - Final Report (.pdf, 3.912 KB).

Download from eHealthNews.eu Portal's mirror: Business Models for eHealth - Final Report (.pdf, 3.912 KB).

Most Popular Now

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...